Financials
Financial year 2025
JV Endocrino from Waregem, company number BE0788332163, closed financial year 2025 with a result of € 199,916 after tax. For that financial year JV Endocrino recorded a gross margin of € 269,467 and equity of € 266,429. Compared with financial year 2024, the result moved from € 53,498 to € 199,916. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 23, 2025.
€ 266,429
▲ € 199,916 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 199,916
▲ 274% vs 2024
Profit after tax over the fiscal year.
€ 308,171
▲ 266% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 261,429.
People and assets in 2025
€ 26,025
▲ € 20,924 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,087
▼ 32% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 63,951
▲ 278% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 13,759 | € 70,547 | € 269,467 | ▲ 282% |
| Profit after taxes | € 9,648 | € 53,498 | € 199,916 | ▲ 274% |
| Equity | € 13,848 | € 66,513 | € 266,429 | ▲ € 199,916 |
| Total debts | € 10,820 | € 23,044 | € 69,003 | ▲ 199% |
| Cash | € 24,431 | € 84,175 | € 308,171 | ▲ 266% |
| Retained profit | € 8,848 | € 61,513 | € 261,429 | ▲ € 199,916 |
| Dividend | € 800 | € 833 | € 0 | ▼ 100% |
| Balance sheet total | € 24,669 | € 89,558 | € 335,433 | ▲ 275% |
Key figures of JV Endocrino, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to JV Endocrino?
What happened at JV Endocrino in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 199,916 (▲ 274% vs 2024). Source: NBB ↗
- New establishment in Kortrijk. KBO
- Start of the company according to the CBE. KBO
- Joke Vliebergh became a director. NBB
In short
From € 9,648 profit in 2023 to € 199,916 profit in 2025.
Paid € 81,052 in corporate taxes since 2023.
Best year ever: 2025, with € 199,916 profit.
Paid out € 1,633 in dividends to the owners in total.
A new publication or filing at JV Endocrino? We notify you, reason included.
Follow JV EndocrinoDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Joke Vliebergh
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Dolagestraat 87
8792 Waregem
President Kennedylaan(Kor) 4
8500 Kortrijk
Active since 7 July 2022
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0788.332.163
- VAT number
- BE 0788.332.163
- Registered office
- Dolagestraat 87, 8792 Waregem
- Names & denominations
- JV Endocrino
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 July 2022
- Peppol
- Active · Active since 10 Dec 2025
- Activities · NACE
Activiteiten van medisch specialisten
Overige zakelijke dienstverlening, neg